Cargando…

Non-alcoholic fatty liver disease (NAFLD): a significant predictor of gestational diabetes mellitus (GDM) and early pregnancy miscarriages—prospective study in Rajarata Pregnancy Cohort (RaPCo)

BACKGROUND AND AIMS: Non-alcoholic fatty liver disease (NAFLD) is increasing globally with a mounting body of evidence on various adverse effects on pregnancy. Yet, prospective studies, especially from low-income and middle-income countries, are lacking in examining the impact of NAFLD in pregnancy....

Descripción completa

Detalles Bibliográficos
Autores principales: Koralegedara, Iresha Sandamali, Warnasekara, Janith Niwanthaka, Dayaratne, Korale Gedara, De Silva, Farika Nirmani, Premadasa, Jagath Keerthi, Agampodi, Suneth Buddhika
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8867246/
https://www.ncbi.nlm.nih.gov/pubmed/35193889
http://dx.doi.org/10.1136/bmjgast-2021-000831
_version_ 1784656013259964416
author Koralegedara, Iresha Sandamali
Warnasekara, Janith Niwanthaka
Dayaratne, Korale Gedara
De Silva, Farika Nirmani
Premadasa, Jagath Keerthi
Agampodi, Suneth Buddhika
author_facet Koralegedara, Iresha Sandamali
Warnasekara, Janith Niwanthaka
Dayaratne, Korale Gedara
De Silva, Farika Nirmani
Premadasa, Jagath Keerthi
Agampodi, Suneth Buddhika
author_sort Koralegedara, Iresha Sandamali
collection PubMed
description BACKGROUND AND AIMS: Non-alcoholic fatty liver disease (NAFLD) is increasing globally with a mounting body of evidence on various adverse effects on pregnancy. Yet, prospective studies, especially from low-income and middle-income countries, are lacking in examining the impact of NAFLD in pregnancy. In this study, we explored the effect of NAFLD on the development of gestational diabetes mellitus (GDM) and early pregnancy miscarriages. METHODS: A population-based prospective cohort study was conducted among first-trimester pregnant women who registered in the national pregnancy care programme during July–September 2019 in Anuradhapura district, Sri Lanka. Baseline clinical–biochemical parameters and ultrasound scan (USS) of the liver were done to assess fatty liver. Those who were normoglycaemic based on WHO criteria were followed up, and a repeat oral glucose tolerance test was performed between 24 and 28 weeks of gestation. RESULTS: Of the 632 pregnant women studied, 90 (14%) and 234 (37%) were diagnosed as having fatty liver grade (FLG) II and I, respectively. The cumulative incidence of GDM in FLG 0, I, and II were 11, 44, and 162 per 1000 pregnancies, respectively. After adjusting for age and other known risk factors, women with FLG II had a relative risk (RR) of 12.5 (95% CI 2.2 to 66.4) for developing GDM compared with FLG 0. In addition, women with FLG I (RR 2.1, 95% CI 1.01 to 4.64) and FLG II (RR 4.5, 95% CI 2.1 to 9.9) were significant risk factors for early pregnancy miscarriages, and FLG II remained as the only independent predictor of miscarriages after adjusting for age, parity, body mass index, blood sugar, blood pressure, and haemoglobin level (adjusted OR 4.2 (95% CI 1.9 to 9.1)). CONCLUSION: In this rural south Asian community, NAFLD is shown to be a major risk factor for GDM and early pregnancy miscarriages. Therefore, routine identification of NAFLD through a simple USS may help in the early identification of high-risk mothers.
format Online
Article
Text
id pubmed-8867246
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-88672462022-03-15 Non-alcoholic fatty liver disease (NAFLD): a significant predictor of gestational diabetes mellitus (GDM) and early pregnancy miscarriages—prospective study in Rajarata Pregnancy Cohort (RaPCo) Koralegedara, Iresha Sandamali Warnasekara, Janith Niwanthaka Dayaratne, Korale Gedara De Silva, Farika Nirmani Premadasa, Jagath Keerthi Agampodi, Suneth Buddhika BMJ Open Gastroenterol Epidemiology BACKGROUND AND AIMS: Non-alcoholic fatty liver disease (NAFLD) is increasing globally with a mounting body of evidence on various adverse effects on pregnancy. Yet, prospective studies, especially from low-income and middle-income countries, are lacking in examining the impact of NAFLD in pregnancy. In this study, we explored the effect of NAFLD on the development of gestational diabetes mellitus (GDM) and early pregnancy miscarriages. METHODS: A population-based prospective cohort study was conducted among first-trimester pregnant women who registered in the national pregnancy care programme during July–September 2019 in Anuradhapura district, Sri Lanka. Baseline clinical–biochemical parameters and ultrasound scan (USS) of the liver were done to assess fatty liver. Those who were normoglycaemic based on WHO criteria were followed up, and a repeat oral glucose tolerance test was performed between 24 and 28 weeks of gestation. RESULTS: Of the 632 pregnant women studied, 90 (14%) and 234 (37%) were diagnosed as having fatty liver grade (FLG) II and I, respectively. The cumulative incidence of GDM in FLG 0, I, and II were 11, 44, and 162 per 1000 pregnancies, respectively. After adjusting for age and other known risk factors, women with FLG II had a relative risk (RR) of 12.5 (95% CI 2.2 to 66.4) for developing GDM compared with FLG 0. In addition, women with FLG I (RR 2.1, 95% CI 1.01 to 4.64) and FLG II (RR 4.5, 95% CI 2.1 to 9.9) were significant risk factors for early pregnancy miscarriages, and FLG II remained as the only independent predictor of miscarriages after adjusting for age, parity, body mass index, blood sugar, blood pressure, and haemoglobin level (adjusted OR 4.2 (95% CI 1.9 to 9.1)). CONCLUSION: In this rural south Asian community, NAFLD is shown to be a major risk factor for GDM and early pregnancy miscarriages. Therefore, routine identification of NAFLD through a simple USS may help in the early identification of high-risk mothers. BMJ Publishing Group 2022-02-22 /pmc/articles/PMC8867246/ /pubmed/35193889 http://dx.doi.org/10.1136/bmjgast-2021-000831 Text en © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/.
spellingShingle Epidemiology
Koralegedara, Iresha Sandamali
Warnasekara, Janith Niwanthaka
Dayaratne, Korale Gedara
De Silva, Farika Nirmani
Premadasa, Jagath Keerthi
Agampodi, Suneth Buddhika
Non-alcoholic fatty liver disease (NAFLD): a significant predictor of gestational diabetes mellitus (GDM) and early pregnancy miscarriages—prospective study in Rajarata Pregnancy Cohort (RaPCo)
title Non-alcoholic fatty liver disease (NAFLD): a significant predictor of gestational diabetes mellitus (GDM) and early pregnancy miscarriages—prospective study in Rajarata Pregnancy Cohort (RaPCo)
title_full Non-alcoholic fatty liver disease (NAFLD): a significant predictor of gestational diabetes mellitus (GDM) and early pregnancy miscarriages—prospective study in Rajarata Pregnancy Cohort (RaPCo)
title_fullStr Non-alcoholic fatty liver disease (NAFLD): a significant predictor of gestational diabetes mellitus (GDM) and early pregnancy miscarriages—prospective study in Rajarata Pregnancy Cohort (RaPCo)
title_full_unstemmed Non-alcoholic fatty liver disease (NAFLD): a significant predictor of gestational diabetes mellitus (GDM) and early pregnancy miscarriages—prospective study in Rajarata Pregnancy Cohort (RaPCo)
title_short Non-alcoholic fatty liver disease (NAFLD): a significant predictor of gestational diabetes mellitus (GDM) and early pregnancy miscarriages—prospective study in Rajarata Pregnancy Cohort (RaPCo)
title_sort non-alcoholic fatty liver disease (nafld): a significant predictor of gestational diabetes mellitus (gdm) and early pregnancy miscarriages—prospective study in rajarata pregnancy cohort (rapco)
topic Epidemiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8867246/
https://www.ncbi.nlm.nih.gov/pubmed/35193889
http://dx.doi.org/10.1136/bmjgast-2021-000831
work_keys_str_mv AT koralegedaraireshasandamali nonalcoholicfattyliverdiseasenafldasignificantpredictorofgestationaldiabetesmellitusgdmandearlypregnancymiscarriagesprospectivestudyinrajaratapregnancycohortrapco
AT warnasekarajanithniwanthaka nonalcoholicfattyliverdiseasenafldasignificantpredictorofgestationaldiabetesmellitusgdmandearlypregnancymiscarriagesprospectivestudyinrajaratapregnancycohortrapco
AT dayaratnekoralegedara nonalcoholicfattyliverdiseasenafldasignificantpredictorofgestationaldiabetesmellitusgdmandearlypregnancymiscarriagesprospectivestudyinrajaratapregnancycohortrapco
AT desilvafarikanirmani nonalcoholicfattyliverdiseasenafldasignificantpredictorofgestationaldiabetesmellitusgdmandearlypregnancymiscarriagesprospectivestudyinrajaratapregnancycohortrapco
AT premadasajagathkeerthi nonalcoholicfattyliverdiseasenafldasignificantpredictorofgestationaldiabetesmellitusgdmandearlypregnancymiscarriagesprospectivestudyinrajaratapregnancycohortrapco
AT agampodisunethbuddhika nonalcoholicfattyliverdiseasenafldasignificantpredictorofgestationaldiabetesmellitusgdmandearlypregnancymiscarriagesprospectivestudyinrajaratapregnancycohortrapco